What If Cross-Linking Doesn't Work for Keratoconus?

Every so often a patient asks the question they’ve been sitting on since the day they were diagnosed: what if the cross-linking doesn’t work? It’s a fair thing to worry about. You’ve been told that one procedure is what stands between you and your keratoconus getting worse, and nobody enjoys resting that much on a single throw of the dice.

So let me answer it properly. Failure is rare. It’s also usually explainable, often preventable, and almost never the end of the road.

How often this actually happens

Cross-linking does what it claims to do. It strengthens the bonds between the collagen fibres in your cornea, and for the large majority of patients that’s the end of the progression story. We keep scanning the cornea for years afterwards and the numbers sit where they were.

When a cornea doesn’t hold, there’s usually one of three explanations behind it. Two of them we can often see coming. The third is entirely in your hands.

The first year doesn’t count

Before anything else, this is where most of the false alarms live.

Cross-linking changes your cornea, which is the entire point of it. But the change doesn’t finish on the day of the procedure. The cornea keeps remodelling for months afterwards, and while it does, your scans move around. Some readings steepen. Some flatten. Vision can wobble.

Patients see a number shift on a topography map and understandably conclude the treatment has failed. It hasn’t. We call this pseudoprogression, and it’s the cross-linking talking rather than the keratoconus. I don’t count anything as progression inside the first twelve months after treatment, and I’d encourage you not to either.

If a cornea is genuinely still progressing, it will still be progressing at eighteen months. That’s the timeframe that means something.

Why it fails on the rare occasions it does

Severe disease at the time of treatment. A cornea that was already very thin, very steep and very advanced when we treated it has less structural reserve to work with. Cross-linking is far more reliable in a cornea we catch early, which is the whole argument for treating keratoconus the moment we’ve confirmed it’s moving rather than waiting to see how bad it gets.

A very young patient. Keratoconus that shows up in a young teenager tends to behave more aggressively than the same disease at twenty-five. These are the patients I watch most closely afterwards, and they’re the ones most likely to need a second round.

Continued eye rubbing. By some distance the most common of the three, and the one entirely within your control.

Keratoconus is a disease of eye rubbing

I want to be direct about this, because being gentle about it hasn’t served patients well.

Keratoconus is, at its core, a disease of eye rubbing. The mechanics aren’t complicated. The cornea is a thin, flexible structure, and repeated mechanical force deforms it. Someone rubbing hard and daily for years is slowly pressing a cone into the front of their own eye.

Cross-linking makes that cornea meaningfully stronger. It doesn’t make it invincible. Go back to rubbing with real force every day and you can absolutely overwhelm a treated cornea, and that is what I see behind most of the genuine progression cases that reach me.

Which is why the most important part of a keratoconus consultation is often the least surgical part: working out why you rub. There’s usually a reason, and it’s usually treatable. Allergic eyes, a dry or irritated ocular surface, a habit built up over years of itch. Treat the itch properly and the rubbing tends to stop on its own. Willpower on its own rarely gets there, because you rub in your sleep, and while you’re concentrating, and without ever noticing you did it. If allergy is your trigger, an allergy management plan does more for your cornea’s long-term future than almost anything else on this page.

Cross-linking can be done again

If your cornea does progress after treatment, and we’ve held our nerve past that twelve-month mark and confirmed it’s real, the procedure can simply be repeated. A second cross-linking usually does the job.

It isn’t common. Most people reading this will never need it. But it matters that the option exists, because it means a disappointing result the first time round isn’t a dead end. It’s a step in a longer plan.

Does CAIRS stop progression? Not proven yet

This question comes up a lot now that CAIRS has become such a large part of keratoconus care, and I’d rather give you a real answer than a comfortable one.

There’s a reasonable theoretical case that adding donor corneal tissue into a thin, weak cornea might stabilise it as well as reshape it. Studies are in progress to test exactly that. We don’t have the answer yet, and I’m not going to claim we do.

So for now the division of labour stands as it always has. Cross-linking is what halts progression. CAIRS is what improves vision. When a patient needs both, we do both. If the research eventually shows CAIRS stabilises the disease in its own right, that will be genuinely good news and I’ll write about it then.

The bottom line

Cross-linking not working is uncommon. Most of what looks like failure in the first year is the cornea settling after treatment rather than the disease advancing, and the right response to a wobbly six-month scan is patience rather than panic.

Where progression is real, it usually traces back to advanced disease at the outset, a very young patient, or hands going into eyes. The first two are reasons to be treated early and watched closely. The third is a reason to take the itch seriously and to stop rubbing, which is the single most useful thing any keratoconus patient can do for themselves.

If you’ve had cross-linking elsewhere and you’re worried it hasn’t held, bring your old scans. Comparing them properly against a new set is the only way to tell real progression from the noise of the first year. Book a consultation and we’ll look at them together. There’s also a broader guide to keratoconus and its treatment options if you’re still getting your bearings after a new diagnosis.

For the full overview of the procedure, recovery timeline and Medicare rebate, see the corneal cross-linking treatment page.